Mauri Davide, Zafeiri Georgia, Yerolatsite Melina, Tsali Lampriani, Zarkavelis Georgios, Tsiara Anna, Polyzos Nikolaos P, Valachis Antonis, Kalopita Konastantina, Kampletsas Eleftherios, Papadaki Alexandra, Peponi Evangelia, Kapoulitsa Fani, Filis Panagiotis, Pentheroudakis Georgios
Department of Medical Oncology, University Hospital of Ioannina, Greece.
Department of Internal Medicine, General Hospital of Arta, Arta, Greece.
Contemp Oncol (Pozn). 2019;23(2):100-109. doi: 10.5114/wo.2019.85882. Epub 2019 Jun 13.
Cancer cachexia is a common associate of cancer and has a negative impact on both patients' quality of life and overall survival. Nonetheless its management remains suboptimal in clinical practice. Provision of medical recommendations in websites is of extreme importance for medical decision making and translating evidence into clinical practice.
To scrutinize the magnitude, consistency and changes over time of cancer-cachexia recommendations for physicians on the Web among oncology related societies. Intercontinental, continental, national and socioeconomic variations were further analyzed.
Web identification of oncology related societies and prospective analyses of relative Web guideline recommendations for physicians on cancer-cachexia at different time-points.
In June 2011, we scrutinized 144,000 Web pages. We identified 275 societies, of which 270 were eligible for analyses: 67 were international (African, American, Asian, European, Oceania and Intercontinental), 109 belonged to the top 10 countries with the highest development index and 94 pertained to 10 countries with a long lasting tradition in medical oncology.
The magnitude of cancer cachexia recommendations for physicians on the Web at a global level was scant both for coverage and consistency, and at any time-point considered: 3.7% (10/270) in 2011 and 8.1% (22/270) in 2018. The proportion of societies giving evidence-based and updated recommendations for cancer cachexia for physicians was only 1.1% (3/270) in 2011 and 2.96% (8/270) in 2018. Continent, national highest developmental index, oncology tradition and economic-geographic areas were not found to influence Web guideline provision.
癌症恶病质是癌症常见的伴随症状,对患者的生活质量和总生存期均有负面影响。尽管如此,其在临床实践中的管理仍不尽人意。网站上提供的医学建议对于医疗决策以及将证据转化为临床实践极为重要。
审视肿瘤相关学会网站上针对医生的癌症恶病质建议的数量、一致性及随时间的变化情况。进一步分析洲际、大陆、国家及社会经济差异。
通过网络识别肿瘤相关学会,并对不同时间点针对医生的癌症恶病质相关网络指南建议进行前瞻性分析。
2011年6月,我们审查了144,000个网页。我们识别出275个学会,其中270个符合分析条件:67个为国际学会(非洲、美洲、亚洲、欧洲、大洋洲及洲际学会),109个属于发展指数最高的前10个国家,94个属于在医学肿瘤学方面有悠久传统的10个国家。
全球范围内,网站上针对医生的癌症恶病质建议在覆盖范围和一致性方面均很欠缺,在任何考虑的时间点都是如此:2011年为3.7%(10/270),2018年为8.1%(22/270)。为医生提供基于证据且更新的癌症恶病质建议的学会比例在2011年仅为1.1%(3/270),2018年为2.96%(8/270)。未发现大陆、国家最高发展指数、肿瘤学传统及经济地理区域对网络指南的提供有影响。